$187 Million Investment Fuels Callio Therapeutics’ Cancer Fight

Innovative approach promise safer, more effective treatments Seattle-based biotech startup Callio Therapeutics has successfully raised $187 million in funding to support its groundbreaking efforts in cancer treatment. This substantial financial backing highlights the growing interest in innovative oncology solutions and positions the company as a key player in the biotech sector. Transforming Cancer Treatment with Innovative Approaches Callio Therapeutics is dedicated to developing transformative cancer therapies that target the disease at its biological roots. By focusing on more e